Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 3, 2011, Pages 650-656

  van der Starre, Willize E ^a   van Nieuwkoop, Cees ^a   Paltansing, Sunita ^a   van't Wout, Jan W ^a,b   Groeneveld, Geert H ^a   Becker, Martin J ^b   Koster, Ted ^c   Wattel Louis, G Hanke ^d   Delfos, Nathalie M ^e   Ablij, Hans C ^f   Leyten, Eliane M S ^b   Blom, Jeanet W ^a   van Dissel, Jaap T ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDICAL CENTER HAAGLANDEN   (Netherlands)

^c GROENE HART HOSPITAL   (Netherlands)

^d N   (Netherlands)

^e RIJNLAND HOSPITAL   (Netherlands)

^f Department of Internal Medicine ^*  (Netherlands)

Author keywords

Antibiotic resistance; Ciprofloxacin; ESBLs; Pyelonephritis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFUROXIME; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CASE CONTROL STUDY; CLINICAL ASSESSMENT; COMMUNITY; CONTROLLED CLINICAL TRIAL; ENTEROCOCCUS FAECALIS; ENVIRONMENTAL FACTOR; ESCHERICHIA COLI; FEMALE; HOSPITALIZATION; HUMAN; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; PROSPECTIVE STUDY; RISK FACTOR; URINARY CATHETER; URINARY TRACT INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FLUOROQUINOLONES; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; URINARY TRACT INFECTIONS;

EID: 79951547248     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq465     Document Type: Article

References (33)

1. Warren JW, Abrutyn E, Hebel JR et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999; 29: 745-58.
2. Wagenlehner FM, Weidner W, Naber KG. Pharmacokinetic characteristics of antimicrobials and optimal treatment of urosepsis. Clin Pharmacokinet 2007; 46: 291-305.
3. Geerlings SE, van den Broek PJ, van Haarst EP et al. [Optimisation of the antibiotic policy in the Netherlands. X. The SWAB guideline for antimicrobial treatment of complicated urinary tract infections]. Ned Tijdschr Geneeskd 2006; 150: 2370-6.
4. Talan DA, Krishnadasan A, Abrahamian FM et al. Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinoloneresistant Escherichia coli infection among emergency department patients with pyelonephritis. Clin Infect Dis 2008; 9: 1150-8.
5. Johnson L, Sabel A, Burman WJ et al. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. Am J Med 2008; 121: 876-84.
6. Talan DA, Stamm WE, Hooton TM et al. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial. JAMA 2000; 283: 1583-90.
7. Arslan H, Azap OK, Ergonul O et al. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from communityacquired urinary tract infections in Turkey. J Antimicrob Chemother 2005; 56: 914-8.
8. Degener JE, de Neeling AJ. Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands. Nethmap 2009. http://www.swab.nl/swab/cms3.nsf/uploads/1D61A8F6E60555F3C125763900414B7B/FILE/nethmap2009_ 21_9-2009.pdf (24 November 2010, date last accessed).
9. Nys S, Terporten PH, Hoogkamp-Korstanje JA et al. Trends in antimicrobial susceptibility of Escherichia coli isolates from urology services in The Netherlands (1998-2005). J Antimicrob Chemother 2008; 62: 126-32.
10. Karlowsky JA, Hoban DJ, Decorby MR et al. Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study. Antimicrob Agents Chemother 2006; 50: 2251-4.
11. Ena J, Amador C, Martinez C et al. Risk factors for acquisition of urinary tract infections caused by ciprofloxacin resistant Escherichia coli. J Urol 1995; 153: 117-20.
12. Killgore KM, March KL, Guglielmo BJ. Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection. Ann Pharmacother 2004; 38: 1148-52.
13. Lin CY, Huang SH, Chen TC et al. Risk factors of ciprofloxacin resistance in urinary Escherichia coli isolates. J Microbiol Immunol Infect 2008; 41: 325-31.
14. Colodner R, Kometiani I, Chazan B et al. Risk factors for community-acquired urinary tract infection due to quinolone-resistant E. coli. Infection 2008; 36: 41-5.
15. Vasquez GA, Siu HR, Luna EM et al. Risk factors for quinolone-resistant Escherichia coli urinary tract infection. Infect Dis Clin Pract 2009; 17: 309-13.
16. Chaniotaki S, Giakouppi P, Tzouvelekis LS et al. Quinolone resistance among Escherichia coli strains from community-acquired urinary tract infections in Greece. Clin Microbiol Infect 2004; 10: 75-8.
17. Johnson JR, Clabots C. Sharing of virulent Escherichia coli clones among household members of a woman with acute cystitis. Clin Infect Dis 2006; 43: e101-8.
18. Johnson JR, Owens K, Gajewski A et al. Escherichia coli colonization patterns among human household members and pets, with attention to acute urinary tract infection. J Infect Dis 2008; 197: 218-24.
19. Johnson JR, Miller S, Johnston B et al. Sharing of Escherichia coli sequence type ST131 and other multidrug-resistant and urovirulent E. coli strains among dogs and cats within a household. J Clin Microbiol 2009; 47: 3721-5.
20. Thorsteinsdottir TR, Haraldsson G, Fridriksdottir V et al. Broiler chickens as source of human fluoroquinolone-resistant Escherichia coli, Iceland. Emerg Infect Dis 2010; 16: 133-5.
21. Wilson ML, Gaido L. Laboratory diagnosis of urinary tract infections in adult patients. Clin Infect Dis 2004; 38: 1150-8.
22. Hooton TM, Samadpour M. Is acute uncomplicated urinary tract infection a foodborne illness, and are animals the source? Clin Infect Dis 2005; 40: 258-9.
23. Johnson JR, Kuskowski MA, Menard M et al. Similarity between human and chicken Escherichia coli isolates in relation to ciprofloxacin resistance status. J Infect Dis 2006; 194: 71-8.
24. Costelloe C, Metcalfe C, Lovering A et al. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 2010; 340: c2096.
25. Murray BE, Mathewson JJ, DuPont HL et al. Emergence of resistant fecal Escherichia coli in travelers not taking prophylactic antimicrobial agents. Antimicrob Agents Chemother 1990; 34: 515-8.
26. Burman WJ, Breese PE, Murray BE et al. Conventional and molecular epidemiology of trimethoprim-sulfamethoxazole resistance among urinary Escherichia coli isolates. Am J Med 2003; 115: 358-64.
27. Colgan R, Johnson JR, Kuskowski M et al. Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis. Antimicrob Agents Chemother 2008; 52: 846-51.
28. Sannes MR, Belongia EA, Kieke B et al. Predictors of antimicrobial-resistant Escherichia coli in the feces of vegetarians and newly hospitalized adults in Minnesota and Wisconsin. J Infect Dis 2008; 197: 430-4.
29. Ramchandani M, Manges AR, Debroy C et al. Possible animal origin of human-associated, multidrug-resistant, uropathogenic Escherichia coli. Clin Infect Dis 2005; 40: 251-7.
30. Smith SP, Manges AR, Riley LW. Temporal changes in the prevalence of community-acquired antimicrobial-resistant urinary tract infection affected by Escherichia coli clonal group composition. Clin Infect Dis 2008; 46: 689-95.
31. Vincent C, Boerlin P, Daignault D et al. Food reservoir for Escherichia coli causing urinary tract infections. Emerg Infect Dis 2010; 16: 88-95.
32. Graziani C, Luzzi I, Corro M et al. Phylogenetic background and virulence genotype of ciprofloxacin-susceptible and ciprofloxacinresistant Escherichia coli strains of human and avian origin. J Infect Dis 2009; 199: 1209-17.
33. Tolun V, Kucukbasmaci O, Torumkuney-Akbulut D et al. Relationship between ciprofloxacin resistance and extended-spectrum b-lactamase production in Escherichia coli and Klebsiella pneumoniae strains. Clin Microbiol Infect 2004; 10: 72-5.